Immuron Ltd ADR Net Income
| IMRN Stock | USD 0.81 0.03 2.98% |
As of the 5th of February, Immuron retains the Standard Deviation of 6.56, risk adjusted performance of (0.12), and Market Risk Adjusted Performance of 3.45. Immuron technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Immuron Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.13 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -4.7 M | -4.9 M | |
| Net Loss | -4.7 M | -4.9 M | |
| Net Loss | -3.4 M | -3.6 M | |
| Net Loss | (0.02) | (0.02) | |
| Net Income Per E B T | 1.04 | 1.00 |
Immuron | Net Income | Build AI portfolio with Immuron Stock |
Evaluating Immuron's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Immuron Ltd ADR's fundamental strength.
Latest Immuron's Net Income Growth Pattern
Below is the plot of the Net Income of Immuron Ltd ADR over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Immuron Ltd ADR financial statement analysis. It represents the amount of money remaining after all of Immuron Ltd ADR operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Immuron's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immuron's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (5.22 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Immuron Net Income Regression Statistics
| Arithmetic Mean | (4,354,148) | |
| Coefficient Of Variation | (45.32) | |
| Mean Deviation | 1,630,243 | |
| Median | (3,786,507) | |
| Standard Deviation | 1,973,378 | |
| Sample Variance | 3.9T | |
| Range | 6.8M | |
| R-Value | (0.44) | |
| Mean Square Error | 3.4T | |
| R-Squared | 0.19 | |
| Significance | 0.08 | |
| Slope | (171,224) | |
| Total Sum of Squares | 62.3T |
Immuron Net Income History
Other Fundumenentals of Immuron Ltd ADR
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Immuron Net Income component correlations
Immuron Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Immuron is extremely important. It helps to project a fair market value of Immuron Stock properly, considering its historical fundamentals such as Net Income. Since Immuron's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Immuron's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Immuron's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could Immuron diversify its offerings? Factors like these will boost the valuation of Immuron. Market participants price Immuron higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Immuron data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.63) | Revenue Per Share | Quarterly Revenue Growth 0.293 | Return On Assets | Return On Equity |
Understanding Immuron Ltd ADR requires distinguishing between market price and book value, where the latter reflects Immuron's accounting equity. The concept of intrinsic value - what Immuron's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Immuron's price substantially above or below its fundamental value.
Please note, there is a significant difference between Immuron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immuron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Immuron's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Immuron 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immuron's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immuron.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in Immuron on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding Immuron Ltd ADR or generate 0.0% return on investment in Immuron over 90 days. Immuron is related to or competes with GeoVax Labs, BioLineRx, Tharimmune, Ainos, OSR Holdings, Lipocine, and SeaStar Medical. Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal ... More
Immuron Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immuron's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immuron Ltd ADR upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 36.62 | |||
| Value At Risk | (12.72) | |||
| Potential Upside | 5.88 |
Immuron Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immuron's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immuron's standard deviation. In reality, there are many statistical measures that can use Immuron historical prices to predict the future Immuron's volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (1.15) | |||
| Total Risk Alpha | (1.66) | |||
| Treynor Ratio | 3.44 |
Immuron February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | 3.45 | |||
| Mean Deviation | 4.27 | |||
| Coefficient Of Variation | (565.61) | |||
| Standard Deviation | 6.56 | |||
| Variance | 43.02 | |||
| Information Ratio | (0.19) | |||
| Jensen Alpha | (1.15) | |||
| Total Risk Alpha | (1.66) | |||
| Treynor Ratio | 3.44 | |||
| Maximum Drawdown | 36.62 | |||
| Value At Risk | (12.72) | |||
| Potential Upside | 5.88 | |||
| Skewness | (0.15) | |||
| Kurtosis | 4.8 |
Immuron Ltd ADR Backtested Returns
Immuron Ltd ADR holds Efficiency (Sharpe) Ratio of -0.15, which attests that the entity had a -0.15 % return per unit of risk over the last 3 months. Immuron Ltd ADR exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immuron's Market Risk Adjusted Performance of 3.45, risk adjusted performance of (0.12), and Standard Deviation of 6.56 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of -0.34, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Immuron are expected to decrease at a much lower rate. During the bear market, Immuron is likely to outperform the market. At this point, Immuron Ltd ADR has a negative expected return of -0.94%. Please make sure to check out Immuron's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Immuron Ltd ADR performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.16 |
Very weak predictability
Immuron Ltd ADR has very weak predictability. Overlapping area represents the amount of predictability between Immuron time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immuron Ltd ADR price movement. The serial correlation of 0.16 indicates that over 16.0% of current Immuron price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.16 | |
| Spearman Rank Test | -0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Immuron Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Immuron Ltd ADR reported net income of (5.22 Million). This is 101.53% lower than that of the Biotechnology sector and 107.45% lower than that of the Health Care industry. The net income for all United States stocks is 100.91% higher than that of the company.
Immuron Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Immuron's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Immuron could also be used in its relative valuation, which is a method of valuing Immuron by comparing valuation metrics of similar companies.Immuron is currently under evaluation in net income category among its peers.
Immuron Current Valuation Drivers
We derive many important indicators used in calculating different scores of Immuron from analyzing Immuron's financial statements. These drivers represent accounts that assess Immuron's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Immuron's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 18.0M | 17.1M | 18.9M | 14.1M | 12.7M | 15.8M | |
| Enterprise Value | (3.9M) | 114.2K | 7.4M | 11.4M | 13.1M | 16.9M |
Immuron Institutional Holders
Institutional Holdings refers to the ownership stake in Immuron that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Immuron's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Immuron's value.| Shares | Ubs Group Ag | 2025-06-30 | 16.3 K | Rhumbline Advisers | 2025-06-30 | 5.9 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 700 | Bnp Paribas Arbitrage, Sa | 2025-06-30 | 100.0 | Sbi Securities Co Ltd | 2025-06-30 | 10.0 | Wells Fargo & Co | 2025-06-30 | 0.0 |
Immuron Fundamentals
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.26 | ||||
| Profit Margin | (0.72) % | ||||
| Operating Margin | (0.86) % | ||||
| Current Valuation | 5.72 M | ||||
| Shares Outstanding | 8.08 M | ||||
| Shares Owned By Institutions | 0.82 % | ||||
| Number Of Shares Shorted | 30.84 K | ||||
| Price To Earning | (2.38) X | ||||
| Price To Book | 1.21 X | ||||
| Price To Sales | 1.01 X | ||||
| Revenue | 7.29 M | ||||
| Gross Profit | 4.77 M | ||||
| EBITDA | (5.31 M) | ||||
| Net Income | (5.22 M) | ||||
| Cash And Equivalents | 22.11 M | ||||
| Cash Per Share | 3.88 X | ||||
| Total Debt | 117.13 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 15.75 X | ||||
| Book Value Per Share | 0.02 X | ||||
| Cash Flow From Operations | (6.14 M) | ||||
| Short Ratio | 0.36 X | ||||
| Earnings Per Share | (0.63) X | ||||
| Target Price | 3.58 | ||||
| Beta | 0.5 | ||||
| Market Capitalization | 7.38 M | ||||
| Total Asset | 10.09 M | ||||
| Retained Earnings | (82.48 M) | ||||
| Working Capital | 8.05 M | ||||
| Current Asset | 7.79 M | ||||
| Current Liabilities | 2.68 M | ||||
| Net Asset | 10.09 M |
About Immuron Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immuron Ltd ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immuron using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immuron Ltd ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Immuron
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immuron position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immuron will appreciate offsetting losses from the drop in the long position's value.Moving together with Immuron Stock
Moving against Immuron Stock
| 0.9 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.69 | DSGN | Design Therapeutics | PairCorr |
| 0.69 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.66 | ENGN | enGene Holdings Common | PairCorr |
| 0.49 | 63E | ONWARD MEDICAL BV | PairCorr |
The ability to find closely correlated positions to Immuron could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immuron when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immuron - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immuron Ltd ADR to buy it.
The correlation of Immuron is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immuron moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immuron Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immuron can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Will Biotechnology sector continue expanding? Could Immuron diversify its offerings? Factors like these will boost the valuation of Immuron. Market participants price Immuron higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Immuron data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.63) | Revenue Per Share | Quarterly Revenue Growth 0.293 | Return On Assets | Return On Equity |
Understanding Immuron Ltd ADR requires distinguishing between market price and book value, where the latter reflects Immuron's accounting equity. The concept of intrinsic value - what Immuron's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Immuron's price substantially above or below its fundamental value.
Please note, there is a significant difference between Immuron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immuron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Immuron's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.